Clinical Study to Evaluate Safety and Dosing of CA9hu-1 in Patients With Advanced Solid Tumours

Clinical trial NCT05698238 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05698238
Sponsor: Mabpro, a.s.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Clear Cell Renal Cell Carcinoma Metastatic TNBC - Triple-Negative Breast Cancer Head and Neck Cancer Non-small-cell Lung Carcinoma Mesothelioma, Malignant

Start date: 2024-01-01
Primary completion: 2026-01-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.